As of 2025-09-15, the Fair Value of Humacyte Inc (HUMA) is -1.86 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.47 USD, the upside of Humacyte Inc is -226.72%.
With the market price of 1.47 USD and our fair value calculation, Humacyte Inc (HUMA) is not a good investment. Investing in HUMA stocks now will result in a potential loss of 226.72%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -66.52 | -26.48 | -11.97 | -111.00 | -149.00 | -72.99 |
| YoY growth | 22.13% | 60.19% | 54.80% | -827.32% | -34.23% | -144.89% |
| Market Cap (mil) | 232.80 |
| P/E | |
| Forward P/E |
| EPS | -0.37 |
| Avg earnings growth rate | -144.89% |
| TTM earnings | -59.00 |